SABCS 2022 Conference Coverage


 

SABCS 2022 on the OPHELIA Study: Olaparib + Trastuzumab in HER2+ BRCAm Advanced Breast Cancer Patients

193 views
January 5, 2023
Comments 0
Login to view comments. Click here to Login